The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

Brenner, BM; Cooper, ME; de, Zeeuw, D; Grunfeld, J-P; Kean, WF; Kurokawa, K; McGill, JB; Mitch, WE; Parving, HH; Ribeiro, AB; Schluchter, MD; Snavely, D; Zhang, Z; Simpson, R; Ramjit, D; Shahnaz, S; Weaver, J

doi:10.3317/jraas.2000.062

The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Brenner BM, Cooper ME, de Zeeuw D, Grunfeld J-P, Kean WF, Kurokawa K, McGill JB, Mitch WE, Parving HH, Ribeiro AB, Schluchter MD, Snavely D, Zhang Z, Simpson R, Ramjit D, Shahnaz S, Weaver J

Publication type: Article

Publication status: Published

Journal: Journal of the Renin-Angiotensin-Aldosterone System

Year: 2000

Volume: 1

Issue: 4

Pages: 328- 335

ISSN (print): 1470-3203

ISSN (electronic): 1752-8976

Publisher: Sage Publications

URL: http://dx.doi.org/10.3317/jraas.2000.062

DOI: 10.3317/jraas.2000.062

Altmetrics

Altmetrics provided by Altmetric

ePrints

The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

Downloads

Publication metadata

Altmetrics

Share